2023-04-25 08:45:00 ET
The bear market for biotech stocks has recently shown signs of slackening, but there are biotech stocks whose shares are already up by 50% or more to start this year.
TG Therapeutics (NASDAQ: TGTX) , Viking Therapeutics (NASDAQ: VKTX) and BeiGene (NASDAQ: BGNE) have attracted investors' interest because they all have new therapies with wide applications that have shown great promise.
TG Therapeutics' launch of Briumvi, a therapy for relapsing multiple sclerosis, has been a quick success , even with competition from two other anti-CD20 monoclonal antibodies already on the market. Thanks to its strong sales, the stock is up more than 90% year to date.
For further details see:
3 Top Biotech Stocks Defying the Bear Market